AGL - Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against agilon health inc. (AGL) | Benzinga

LOS ANGELES, April 03, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 20, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired agilon health, inc. ("agilon" or the "Company") (NYSE:AGL) common stock between November 4, 2022 and January 4, 2024, inclusive (the "Class Period").

If you suffered a loss on your agilon investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/agilon-health-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On November 2, 2023, agilon released its third quarter 2023 financial results, reporting lower-than-expected numbers due to increased utilization and medical costs. Additionally, the Company lowered its full-year guidance, stating that it had increased its incurred-but-not-reported ("IBNR") reserve to account for prior expenses.

On this news, agilon's stock price fell $2.23, or 13.2%, to close at $14.66 ...

AGL)>Full story available on Benzinga.com